相关实验视频

Updated: May 4, 2026

In vitro Reconstitution of the Active T. castaneum Telomerase

In vitro Reconstitution of the Active T. castaneum Telomerase

Published on: July 14, 2011

构成性人体端粒酶逆转录酶表达增强了内皮原生细胞的再生特性

Satoshi Murasawa¹, Joan Llevadot, Marcy Silver

¹Department of Medicine (Vascular Medicine, Cardiology, Cardiovascular Research), St Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Mass 02135, USA.

|August 28, 2002

概括

人类端粒酶逆转录酶 (hTERT) 基因转移增强了内皮原生细胞 (EPC) 的再生特性,改善了新血管化. 这为缺血性疾病提供了新的治疗策略.

科学领域:

再生医学是一种再生医学.
分子生物学分子生物学
心血管研究研究心血管研究

背景情况:

端粒酶是细胞寿命的关键调节者.
内皮原生细胞 (EPC) 在新血管化中起着至关重要的作用.
研究端粒酶在EPC中的作用对于理解再生过程至关重要.

研究的目的:

研究人类端粒酶逆转录酶 (hTERT) 基因转移对EPCs的影响.
评估增强端粒酶活性对EPC再生特性和新血管化的影响.
探索对缺血性疾病的潜在治疗应用.

主要方法:

将hTERT的基因转移到EPC中.
测定端粒酶活性,线粒发生能力和细胞迁移.
在饥饿和血管内皮生长因子 (VEGF) 刺激下评估EPC存活率.
在体外分化成内皮细胞.
在体内移植研究以评估肢体缺血模型中的新血管化.

主要成果:

hTERT基因转移显著增强了EPC中的端粒酶活性.
转化后的EPCs表现出增加的线粒体发生能力和迁移.
hTERT过度表达拯救了EPC从亡中脱离,并促进了分化.
在体内研究显示,在产后新血管化和肢体救援方面有4倍的改善.

结论:

端粒酶活性对于EPC血管性质至关重要,包括线粒发生,迁移和生存.
hTERT基因转移增强了EPC的再生能力.
这种方法为通过改善新血管化来治疗严重缺血性疾病提供了一个有希望的治疗策略.

更多相关视频

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation

Published on: October 20, 2014

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

相关概念视频

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

Somatic to iPS Cell Reprogramming

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...

Chromatin Modification in iPS Cells

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...

Methods of Nuclear Reprogramming

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...